Stanabol Tablets

General information:

CAS Name: (5a,17b)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol

Stanozolol is a17-alpha-alkylated anabolic steroid with
good oral bioavailability. While stanazolol’s androgenic activity
index of stanozolol is nearly the same as testosterone, its
myotrophic activity is much higher at 2.0–3.7. Stanozolol does not
aromatize and does not cause water retention.

Stanozolol has been used for weight loss management in HIV
patients with chronic obstructive pulmonary disease and has showed
significant improvement in weight, body mass index, LBM, and muscle
size. Stanozolol has been shown in vitro to significantly enhance
collagen synthesis. A positive effect of stanazolol on wound healing
in patients with non-healing wounds has also been demonstrated.
Clinical studies show that the treatment with stanozolol during the
induction phase of chemotherapy results in a positive effect on the
duration of cancer-free remission.

each tablet contains:

Stanozolol

USP

10 mg

Excipients

q.s.

Packing: 100 tablets in a 10 blisters

Additional information:

As with all 17-alpha-alkylated oral steroids, stanazolol
has some liver toxicity especially with increases in daily dose and
therapy duration. But long-term study of patients treated with
stanozolol and followed for 15–47 months did not show any harmful
effect on the liver.

Stanozolol has negative effect on
cholesterol profile rise in LDL and decrease in HDL. 6 weeks oral
stanozolol at a dose of 6 mg/day resulted in a more adverse lipid
profile than an IM injection of of 200 mg/wk testosterone. During
stanozolol treatment, HDL level can be decrease as much as 30-40%.